TP53 and neoplasm: There are two compounds (FT827 and FT671)that can inhibit USP7 with high specificity and affinity, and FT671 can destabilize USP7 substrate, increase p53 level, cause p53 target gene transcription, induce tumor suppressor p21 expression, and inhibit the mice tumor growth (121).